The conference, held at The Wellcome Trust Sanger Institute, highlighted CRISPR research from European and private sector scientists in particular.
Along with breast, ovarian, and pancreatic cancers, the "signature 3" mutation pattern was detected in around 10 percent of sequenced gastric tumors.
The arrayed lentiviral CRISPR/Cas9 guide RNA libraries provide the tools to knock out every known human or mouse protein-coding gene.
Researchers sequenced the whole genomes of nearly 4,000 individuals and the exomes of nearly 6,000 individuals, and created a genotype reference panel.
In a study published in PNAS, the researchers found that the bacteria has split into three distinct species and is developing multiple clones that are highly virulent or drug resistant.
Researchers at the Manchester Centre for Genomic Medicine are using the platform to identify genetic alterations tied to cancer and developmental disorders and disabilities.
A comparative genomics approach finds that the ancestors of Eurasians likely took the northern route out of Africa through Egypt.
Researchers from the Sanger Institute used genomic sequencing to study how somatic mutations build up prior to becoming cancerous.
Of 1,832 typhoid samples sequenced from 63 countries, 47 percent originated from a multi-drug resistant stain known as H58.
Researchers profiled genetic patterns in nearly two-dozen individuals from the Kalash population, a culturally distinct group living in the Hindu Kush mountain range.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.